This article is an erratum on:
Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer
by Jansson H, Cornillet M, Sun D, Filipovic I, Sturesson C, O’Rourke CJ, Andersen JB, Björkström NK and Sparrelid E (2023) Front. Oncol. 13:1169537. doi: 10.3389/fonc.2023.1169537
Due to a production error, there was a mistake in the legend for Figure 1 as published. The term “pCCA” was incorrectly formatted as “PCCA”. The correct legend appears below. The publisher apologizes for this mistake.
FIGURE 1
Figure 1 Study flow chart for the inclusion of patients with BTC. BTC, biliary tract cancer; GBC, gallbladder cancer; iCCA, intrahepatic cholangiocarcinoma; pCCA, perihilar cholangiocarcinoma.
The original version of this article has been updated.
Keywords: cholangiocarcinoma (CCA), gallbladder cancer (GBC), prognostic biomarkers, tumor associated macrophage (TAM), biliary tract cancer (BTC)
Citation: Frontiers Production Office (2023) Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer. Front. Oncol. 13:1281693. doi: 10.3389/fonc.2023.1281693
Received: 22 August 2023; Accepted: 22 August 2023;
Published: 27 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org